Kratom, a tropical tree-derived substance traditionally used by people seeking relief from opioid or alcohol addiction, is increasingly marketed as a wellness product. Manufacturers pitch the capsules, powders, and drinks on wellness podcasts and social media, or distribute free samples at gyms to promote athletic performance, focus, and energy. However, marketing campaigns frequently omit the risk of dependency, seizures, liver injury, and fatal overdoses associated with the drug.
Federal regulators have not approved kratom for medical use. While some states have banned or restricted sales to minors, the substance remains widely available online, in smoke shops, and at gas stations. Doctors express particular concern over potent synthetic and semi-synthetic derivatives like 7-OH and M.G.P.I., the latter of which functions as an opioid and has been linked to numerous fatal overdoses.
Consumers drawn to the product through wellness branding often experience unexpected addiction. Hilary Tesluck, 30, began taking kratom to manage anxiety, viewing it as a harmless wellness supplement. Her usage escalated until she was consuming up to 100 capsules a day, ultimately realizing she was addicted when she ran out during a snowstorm and suffered severe withdrawal symptoms including body aches and sweating. Others, including podcast host Jason Ellis and consumers of brand-name tonics like Feel Free, reported heavy dependency, financial strain, and severe withdrawal after encountering the products through athletic and influencer partnerships.
Industry representatives maintain that their products pose minimal risk when consumed according to serving guidelines, though companies have adjusted labeling and marketing practices following scrutiny, lawsuits, and public health concerns. Addiction experts emphasize that the commercial framing of kratom creates a false sense of safety, leaving vulnerable populations—including individuals with past substance abuse histories—at high risk of addiction.
